© 2024 Boise State Public Radio
NPR in Idaho
Play Live Radio
Next Up:
0:00
0:00
0:00 0:00
Available On Air Stations

Idaho Matters Doctors Roundtable: July 20, 2022

Nurse manager Lucy Golding draws up doses of the Moderna COVID-19 vaccine March 14 in Stamford, Conn. Moderna has begun enrolling infants and young children into a vaccine trial.
John Moore
/
Getty Images
Nurse manager Lucy Golding draws up doses of the Moderna COVID-19 vaccine March 14 in Stamford, Conn. Moderna has begun enrolling infants and young children into a vaccine trial.

For people who have been waiting for a more traditional COVID-19 vaccine, health experts say that Novavax vaccine may be for you.

Late last week, regulators authorized the nation's first so-called protein vaccine and this week the CDC gave it a thumbs up. Joining Idaho Matters to talk more about this, plus other COVID-19 issues is Dr. David Pate, former CEO of St. Luke's Health System and a current member of the Idaho Coronavirus Task Force.

Stay Connected
Hi! I’m Gemma Gaudette, the host of the award-winning show, Idaho Matters. During the day you’ll find me researching and writing about all the fascinating topics we tackle on our show. And of course, at noon, each weekday you’ll find me live behind the microphone as Idaho Matters airs.

You make stories like this possible.

The biggest portion of Boise State Public Radio's funding comes from readers like you who value fact-based journalism and trustworthy information.

Your donation today helps make our local reporting free for our entire community.